Literature DB >> 6842726

Adriamycin permeability of the rat bladder under different conditions.

U Engelmann, R A Bürger, J H Rumpelt, G H Jacobi.   

Abstract

Fifty female Sprague-Dawley rats were treated with 1.4 or 2.4 mg. adriamycin intravesically. Radioimmunological measurement of serum concentrations were performed up to 3 hours post-instillation in normal bladder mucosa, cystitis, and after electrocoagulation, under different filling conditions, as well as with the use of a detergent (Tween 80). The serum concentrations achieved were markedly higher after electrocoagulation or cystitis; altogether they reached only 1/6,000 of the instilled concentration. These studies on the rat bladder suggest that perioperative instillation of adriamycin to prevent recurrence is not contraindicated shortly before or after transurethral resection (TUR) of superficial bladder tumors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6842726     DOI: 10.1016/s0022-5347(17)52401-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.

Authors:  C N Parris; J R Masters; M C Walker; B Newman; P Riddle; P English
Journal:  Urol Res       Date:  1987

2.  Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer.

Authors:  M G Wientjes; R A Badalament; J L Au
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Organ distribution of Adriamycin after intravesical instillation with or without Tween 80 in the rat.

Authors:  S Hellsten; B Axelsson; S Eksborg; C Lindkvist
Journal:  Urol Res       Date:  1988

4.  Absorption of Adriamycin into the systemic circulation after intravesical instillation with or without Tween 80 in the rat.

Authors:  S Hellsten; S Eksborg; B Axelsson
Journal:  Urol Res       Date:  1987

5.  Permeability of the rat bladder to Cisplatinum under different conditions: comparison with Mitomycin C and Adriamycin.

Authors:  U Engelmann; G Oelsner; R A Bürger; H Wagner
Journal:  Urol Res       Date:  1983
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.